How AI Is Changing Drug Discovery at Isomorphic Labs

Max Jaderberg, President, Isomorphic Labs, discusses how AI is accelerating scientific discovery and opening new approaches to drug development with Bloomberg’s Shirin Ghaffary at the 2026 Bloomberg Tech in London. (Source: Bloomberg)

Read the full story at Bloomberg AI ↗

Timeline · 1 report

2026-11-03 13:47 · Bloomberg AI
How AI Is Changing Drug Discovery at Isomorphic Labs

More stories

Runway News | Runway Dev is in Claude Code, Codex and Cursor — Runway Research
Marvell to Acquire Lumentum in $115 Billion All-Stock AI Optics Deal — DigiTimes Asia
Schools Will Lose Google Search If They Say No To Google AI — Forbes AI
OpenAI hires former Army Secretary Dan Driscoll as senior counselor for national security — OpenAI News
OpenAI is finally merging ChatGPT’s Chat and Work tabs — TechCrunch AI
Anthropic plans to sell $3.5 billion of shares to Japan investors in IPO, filing shows — Reuters AI
Abu Dhabi's ADNOC, G42 sign deal with OpenAI as Sam Altman travels to UAE — Reuters AI
Oracle cancels $7bn Tencent AI deal under Trump pressure — Financial Times AI

Get the daily brief of stories like this at 6:30 every morning →